In the News

Share
1713 News Items found
Q&A
Linde Miles
Meet Linde Miles, Winner of a Kravis WiSE Postdoctoral Fellowship
Dr. Miles is a postdoctoral fellow in the Human Oncology and Pathogenesis Program at MSK studying the genetics of blood cancers.
Q&A
Mohita Tagore, a postdoctoral fellow in the Sloan Kettering Institute
Meet Mohita Tagore, Winner of a Kravis WiSE Postdoctoral Fellowship
Dr. Tagore is a postdoctoral fellow in the Cancer Biology and Genetics Program at the Sloan Kettering Institute studying cell communication in cancer.
Jason Lewis, PhD
Science Spotlight: How Jason Lewis, PhD, Defies Limits of Antibodies in Imaging
During the June 8 edition of “MSK Science Spotlight,” radiochemist Jason Lewis, PhD, will share his perspectives on “Defying the Limitations of Antibodies for Imaging and Endoradiotherapy.”
The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
Design and Construction of the David H. Koch Center for Cancer Care Recognized by Industry Leaders
The David H. Koch Center for Cancer Care has recently been recognized by a number of industry leaders for its innovative and resilient design, some of the many features that put the 750,000 square foot facility in a class of its own.
David Solit, MD
Dr. Solit on Actionable Cancer Genomes in “MSK Science Spotlight”
David Solit, MD, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, is the featured speaker for the June 3 episode of “MSK Science Spotlight.”
In the Clinic
MSK radiation oncologist Beryl McCormick confers with a patient
Will Radiation Therapy Protect Me from Breast Cancer Recurrence after Surgery? What to Know
Learn about the role of radiation therapy in protecting women from breast cancer recurrence after breast-conserving surgery.
Ron Vale, PhD
Dr. Massagué to Host June 1 “MSK Science Spotlight” featuring Dr. Ron Vale
June’s “MSK Science Spotlight” segments kick off on Monday, June 1, featuring the honoree of the Katharine Berkan Judd Award Lectureship, Ron Vale, PhD, Vice President and Executive Director, Janelia Research Campus at the Howard Hughes Medical Institute.
Dr.  Zsofia Stadler
ASCO 2020: First Comprehensive Assessment Highlights the Importance of Germline Analysis in Advanced-Cancer Patients
During the upcoming ASCO Virtual Scientific Program, MSK Medical Oncologist Zsofia K. Stadler, MD, will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted therapeutic interventions in a pan-cancer patient population, or a population with similarities and differences among the genomic and cellular alterations found across their diverse tumor types.
Event
MSK leadership on the stage in the Zuckerman Research Center auditorium.
MSK’s Virtual Convocation and Commencement Honors Graduates and Award Winners
Memorial Sloan Kettering’s 41st annual ceremony recognized graduates and award winners with an online event.
Q&A
Two doctors looking at a patient
Answers to Common Questions about Radiation Safety
MSK radiation therapy experts set the record straight about the safety of this effective treatment.